Nonin Technology is Advanced Technology
Advanced Technology for Proven Performance
Oximetry equipment uses near-infrared spectroscopy to measure blood oxygenation levels in the brain and other tissues. Those measurements can be affected by factors such as extraneous tissue, ambient light, variations in skin pigmentation, and the presence of myelin (in the case of infants and neonates). Sensors with only one emitter are more vulnerable to errors as a result of these factors.
Dual Emitter, Dual Detector Architecture
Nonin technology uses two emitters and two detectors in each sensor, plus patented algorithms, to create light paths through surface tissue and the cerebral cortex. This minimizes interference from extraneous tissue, variations in skin pigmentation, and ambient light. The resulting measurements are proven to be the industry’s least affected by intervening tissue or surface effects.1
Dynamic Compensation™ Algorithm
Cerebral oximetry is used in critical care environments to reduce potential complications in pediatric and neonatal surgery. Premature infants, and children with congenital heart disease (CHD), are vulnerable to neurologic complications due to cerebral hypoxia-ischemia.
These patients can have a broad range of brain development and associated tissue differences. But technologies that are not designed to account for these differences can provide inaccurate readings.
Dynamic Compensation, an exclusive, patent-pending Nonin algorithm, incorporates real-time information from the tissue being examined to eliminate the impact of myelin (a light chromophore) on the signal accuracy. This Dynamic Compensation algorithm along with sensors designed specifically for neonate and infant populations, ensures accurate information clinicians can trust without adjusting settings.
Responsive Readings for Improved Outcomes
The objective of this study was to compare three commercial systems to determine if cerebral oxygen saturation measurements accurately account for signal contamination from extracranial tissue.
Adult Sensor Validation
Trending accuracy may be affected by individuals whose oximetric values are outside the expected range. This study validates that Nonin cerebral oximetry is capable of absolute accuracy.
SenSmart® 8006 Hybrid Sensor
Research suggests that rSO2 monitoring can help clinicians respond more effectively to desaturations, which are correlated with higher costs and adverse health outcomes.
The SenSmart 8006 hybrid system incorporates a reusable sensor and disposable patient interface, bringing this technology within reach of more hospitals.
Clinicians in three facilities used SenSmart 8006 sensors in six cardiovascular operating rooms to monitor a total of 89 patients. They said the system performed as well as disposable sensors, and was just as easy to use—while minimizing cost and waste.
Up to 300 uses per reusable sensor yields significant cost savings and reduces waste
Estimated 40-50%2 average reduction in annual sensor spend